Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2020 1
2022 13
2023 13
2024 6
2025 1
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs.
Gremke N, Besong I, Stroh A, von Wichert L, Witt M, Elmshäuser S, Wanzel M, Fromm MF, Taudte RV, Schmatloch S, Karn T, Reinisch M, Hirmas N, Loibl S, Wündisch T, Litmeyer AS, Jank P, Denkert C, Griewing S, Wagner U, Stiewe T. Gremke N, et al. Signal Transduct Target Ther. 2025 Mar 21;10(1):92. doi: 10.1038/s41392-025-02180-4. Signal Transduct Target Ther. 2025. PMID: 40113784 Free PMC article.
Antihypertensive Therapy and Incidence of Cancer.
Loosen SH, Schöler D, Luedde M, Eschrich J, Luedde T, Gremke N, Kalder M, Kostev K, Roderburg C. Loosen SH, et al. Among authors: gremke n. J Clin Med. 2022 Nov 8;11(22):6624. doi: 10.3390/jcm11226624. J Clin Med. 2022. PMID: 36431100 Free PMC article.
[Clinically relevant molecular pathological diagnostics in breast cancer].
Rodepeter FR, Teply-Szymanski J, Romey M, Grass A, Erber R, Lebeau A, Mack EKM, Tarawneh TS, Gremke N, Boekhoff J, Wündisch T, Wagner U, Jank P, Denkert C. Rodepeter FR, et al. Among authors: gremke n. Pathologie (Heidelb). 2023 Feb;44(1):39-49. doi: 10.1007/s00292-022-01175-0. Epub 2023 Jan 11. Pathologie (Heidelb). 2023. PMID: 36629894 Review. German.
CRISPR-Cas9-based target validation for p53-reactivating model compounds.
Wanzel M, Vischedyk JB, Gittler MP, Gremke N, Seiz JR, Hefter M, Noack M, Savai R, Mernberger M, Charles JP, Schneikert J, Bretz AC, Nist A, Stiewe T. Wanzel M, et al. Among authors: gremke n. Nat Chem Biol. 2016 Jan;12(1):22-8. doi: 10.1038/nchembio.1965. Epub 2015 Nov 23. Nat Chem Biol. 2016. PMID: 26595461 Free PMC article.
37 results